Helena F. Florindo

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

Intracranial Breast Cancer Brain Metastases Mouse Model for Immune and Stromal Cells Characterization in Meninges and Olfactory Bulb.

Intracranial Breast Cancer Brain Metastases Mouse Model for Immune and Stromal Cells Characterization in Meninges and Olfactory Bulb.

Journal: Journal of visualized experiments : JoVE
Published: June 29, 2026

XVth Spanish-Portuguese Conference on controlled drug delivery: New horizons in drug delivery.

XVth Spanish-Portuguese Conference on controlled drug delivery: New horizons in drug delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 21, 2026

Bifunctional Phagocytic Synapse Enhancers Remodel the Tumor Microenvironment to Overcome Immunosuppression.

Bifunctional Phagocytic Synapse Enhancers Remodel the Tumor Microenvironment to Overcome Immunosuppression.

Journal: Cancer research
Published: December 09, 2025

Harnessing pre-existing measles immunity: mRNA-Lipid nanoparticle-mediated measles hemagglutinin expression boosts antitumor CD8⁺ T cell responses.

Harnessing pre-existing measles immunity: mRNA-Lipid nanoparticle-mediated measles hemagglutinin expression boosts antitumor CD8⁺ T cell responses.

Journal: Signal transduction and targeted therapy
Published: October 30, 2025

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 22, 2025

A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery.

A rationally designed polypeptide-based hybrid platform for targeted intranasal brain drug delivery.

Journal: Biomaterials
Published: August 18, 2025

Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I.

Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I.

Journal: Molecular therapy. Oncology
Published: March 21, 2025

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Polymeric-based neoantigen nanovaccine synergizes with PD-1/PD-L1 modulators, reprogramming the melanoma microenvironment.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 21, 2025

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.

Radiation-guided nanoparticles enhance the efficacy of PARP inhibitors in primary and metastatic BRCA1-deficient tumors via immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 17, 2024

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.

Journal: Science advances
Published: December 13, 2024

Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma.

Off-The-Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: November 10, 2024

Harnessing sulfur-doped carbon nanodots conjugated with IDO inhibitors act as a dual-mode breast cancer immunotherapy.

Harnessing sulfur-doped carbon nanodots conjugated with IDO inhibitors act as a dual-mode breast cancer immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 18, 2024
Showing 1-12 of 59

Last Updated: 09/26/2026